Sami-Sabinsa Group Invests Rs. 3.30 crore in Captive Renewable Energy to Power its Karnataka Facilities

Sami-Sabinsa Group Limited, a research-focused global health science company,has signed a mutual agreement with O2 Renewable Energy VIII Private Limited to establish a total installed capacity of 240 MW(100 MW of wind and 140 MW AC of solar) for...

Cadila Pharma Fund Rs 200 Cr in new API Manufacturing Plant at Dahej

Cadila Pharmaceuticals, located in Ahmedabad, has opened its state-of-the-art Active Pharmaceutical Ingredients (API) Plant in Dahej, Bharuch district. The Rs 200 crore facility is outfitted with the latest Distributed Control System (DCS)...

MC2 Therapeutics Commences Patient Enrolment To Treat Skin Disease

MC2 Therapeutics announced the enrollment of the first patients in a phase 2 proof-of-concept trial evaluating the safety and efficacy of MC2-25 VLS, an innovative new drug candidate for the treatment of urea-associated skin diseases, including...

Medicure Secures USFDA Nod To Treat Rare Paediatric Disease

Medicure Inc announced that the FDA has granted full approval to enroll patients in its pivotal phase 3 clinical trial to evaluate the use of its investigational product MC-1 for the treatment of pyridox(am)ine 5'-phosphate oxidase (PNPO)...

Rusan Pharma Fund 300 Crores in New API Facility in MP's Pithampur

A new active pharmaceutical ingredient (API) factory was opened by the pharmaceutical business Rusan Pharma. With an annual production capacity of 400 metric tons of APIs, this plant is estimated to generate over 300 employment. The factory is...

Enzene Biosciences Uveils ranibizumab To Treat Neovascular AMD

Following the approval of bevacizumab for the treatment of metastatic colorectal cancer, Pune-based Enzene Biosciences has now launched ranibizumab, a biosimilar of the originator medication Lucentis, which is sold in India under the brand name...

Impact of Digital Therapeutics in Patient-Centric Healthcare

DTx can be utilized independently or along with conventional treatments such as medication, face-to-face therapy, as well as various hardware, sensory, or mechanical devices.

Simcere Pharma and Connect Sign Pact For Innovative Autoimmune Drug

Simcere Pharmaceutical Group Limited (Simcere) and Connect Biopharma HongKong Limited (Connect) have entered into an exclusive licensing and partnership agreement for Rademikibart, a novel IL-4Ra monoclonal antibody. Pursuant to the Agreement...

Bracco and Ulrich Medical Partner For Syringeless MR Injectors

Bracco announced a new long-term agreement that would deliver a Bracco-branded cutting-edge MR injector to the United States under an exclusive private label agreement. The two companies also announced the submission of a 510(k) premarket...

Strides Secures US FDA Appoval For Generic Surprep

Strides Pharma Science's step-down fully owned subsidiary, Strides Pharma Global Pte. Singapore, has acquired FDA clearance for sodium sulphate, potassium sulphate, and magnesium sulphate oral solution 17.5g/ 3.13g/ 1.6g per 6 ounces (product)...

© 2024 India Pharma Outlook. All Rights Reserved.